These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 20545600)
1. Treatment with p38 inhibitor intensifies the death of MG132-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion. Han YH; Kim SZ; Kim SH; Park WH Drug Chem Toxicol; 2010 Oct; 33(4):367-76. PubMed ID: 20545600 [TBL] [Abstract][Full Text] [Related]
2. The changes of reactive oxygen species and glutathione by MG132, a proteasome inhibitor affect As4.1 juxtaglomerular cell growth and death. Han YH; Park WH Chem Biol Interact; 2010 Mar; 184(3):319-27. PubMed ID: 20100472 [TBL] [Abstract][Full Text] [Related]
3. p38 inhibitor intensified cell death in antimycin A-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion. Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH Anticancer Res; 2009 Nov; 29(11):4423-31. PubMed ID: 20032388 [TBL] [Abstract][Full Text] [Related]
4. Proteasome inhibitor MG132 reduces growth of As4.1 juxtaglomerular cells via caspase-independent apoptosis. Han YH; Park WH Arch Toxicol; 2010 Sep; 84(9):689-98. PubMed ID: 20449726 [TBL] [Abstract][Full Text] [Related]
5. The attenuation of MG132, a proteasome inhibitor, induced A549 lung cancer cell death by p38 inhibitor in ROS-independent manner. Han YH; Moon HJ; You BR; Park WH Oncol Res; 2010; 18(7):315-22. PubMed ID: 20377132 [TBL] [Abstract][Full Text] [Related]
6. MG132, a proteasome inhibitor-induced calf pulmonary arterial endothelial cell growth and death, are changed by MAPK inhibitors. You BR; Park WH Drug Chem Toxicol; 2011 Jan; 34(1):45-52. PubMed ID: 20954830 [TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells. Park WH Hum Exp Toxicol; 2011 Dec; 30(12):1945-54. PubMed ID: 21421692 [TBL] [Abstract][Full Text] [Related]
8. Pyrogallol-induced As4.1 juxtaglomerular cell death is attenuated by MAPK inhibitors via preventing GSH depletion. Han YH; Park WH Arch Toxicol; 2010 Aug; 84(8):631-40. PubMed ID: 20191265 [TBL] [Abstract][Full Text] [Related]
9. Treatment with p38 inhibitor partially prevents Calu-6 lung cancer cell death by a proteasome inhibitor, MG132. Han YH; Park WH Cancer Genet Cytogenet; 2010 Jun; 199(2):81-8. PubMed ID: 20471510 [TBL] [Abstract][Full Text] [Related]
10. The effects of MAPK inhibitors on a proteasome inhibitor, MG132-induced HeLa cell death in relation to reactive oxygen species and glutathione. Han YH; Park WH Toxicol Lett; 2010 Feb; 192(2):134-40. PubMed ID: 19854251 [TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species and glutathione level changes by a proteasome inhibitor, MG132, partially affect calf pulmonary arterial endothelial cell death. Han YH; Kim SZ; Kim SH; Park WH Drug Chem Toxicol; 2010 Oct; 33(4):403-9. PubMed ID: 20088736 [TBL] [Abstract][Full Text] [Related]
12. Tempol inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and apoptosis. Han YH; Park WH Oncol Rep; 2012 Mar; 27(3):842-8. PubMed ID: 22024718 [TBL] [Abstract][Full Text] [Related]
13. Attenuation of MG132-induced HeLa cell death by N-acetyl cysteine via reducing reactive oxygen species and preventing glutathione depletion. Han YH; Yang YM; Kim SZ; Park WH Anticancer Res; 2010 Jun; 30(6):2107-12. PubMed ID: 20651358 [TBL] [Abstract][Full Text] [Related]
14. The effects of N-acetyl cysteine on the MG132 proteasome inhibitor-treated lung cancer cells in relation to cell growth, reactive oxygen species and glutathione. Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH Int J Mol Med; 2010 Apr; 25(4):657-62. PubMed ID: 20198316 [TBL] [Abstract][Full Text] [Related]
15. Intracellular glutathione levels are involved in carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone-induced apoptosis in As4.1 juxtaglomerular cells. Han YH; Park WH Int J Mol Med; 2011 Apr; 27(4):575-81. PubMed ID: 21258765 [TBL] [Abstract][Full Text] [Related]
16. MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion. Park WH; Kim SH Oncol Rep; 2012 Apr; 27(4):1284-91. PubMed ID: 22266922 [TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibition by MG132 induces growth inhibition and death of human pulmonary fibroblast cells in a caspase-independent manner. You BR; Park WH Oncol Rep; 2011 Jun; 25(6):1705-12. PubMed ID: 21399877 [TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis. Han YH; Kim SZ; Kim SH; Park WH Am J Physiol Renal Physiol; 2007 Aug; 293(2):F511-20. PubMed ID: 17507598 [TBL] [Abstract][Full Text] [Related]
19. The enhancement of propyl gallate-induced apoptosis in HeLa cells by a proteasome inhibitor MG132. You BR; Park WH Oncol Rep; 2011 Mar; 25(3):871-7. PubMed ID: 21186403 [TBL] [Abstract][Full Text] [Related]
20. Pyrogallol, ROS generator inhibits As4.1 juxtaglomerular cells via cell cycle arrest of G2 phase and apoptosis. Park WH; Han YH; Kim SH; Kim SZ Toxicology; 2007 Jun; 235(1-2):130-9. PubMed ID: 17442475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]